← All posts
·9 min read

Bumrungrad vs Samitivej vs BNH vs BDMS Wellness: the Bangkok premium-hospital comparison for GLP-1 in 2026

The four Bangkok premium hospitals scored on Panya's 11-signal rubric: Bumrungrad, Samitivej Sukhumvit, BNH, and BDMS Wellness Clinic. JCI accreditation, real GLP-1 menu depth, BDMS-group concentration, and how Thailand-resident expats actually pick.

Thailand is the cheapest legitimate GLP-1 channel in Asia. Most of that legend got built on Bangkok's mid-tier and aesthetic-clinic layer — the Ekkamai longevity practices, the Sukhumvit cash-pay clinics, the research-grade direct vendors with COA pages. Less written about is the premium hospital layer: the four big names a Thailand-resident expat with international insurance or a serious medical history would actually book.

This is the version of the comparison we wish we had when we audited the Bangkok premium tier for our cohort-1 anchor routing. JCI accreditation is the floor; what differs is the depth of the GLP-1 menu, how transparent the pricing is, and a real audit theme around BDMS-group concentration.

What "premium hospital" means here

The four names in this guide all share the JCI accreditation and the international-medical-tourism scale. None of them are mainly weight-loss clinics. All of them prescribe GLP-1 — some with published packages, some only via endocrinology consult, some exclusively as part of a longevity stack.

That difference matters. A buyer flow that is "I just want a Mounjaro pen and a clean dose ramp" wants a different anchor than a buyer flow that is "I want a baseline metabolic workup, a CGM, and a 6-month obesity-coded follow-up programme." The four hospitals split cleanly across that spectrum.

Per-hospital scorecard, April 2026

We score each hospital on the published 11-signal rubric. Final scores are at panya.health/vendor on the live scorecard pages, with regulatory + clinical sources audited against. What follows is the buyer's-eye summary.

Bumrungrad International Hospital — 76 / 100, routable

The most-cited Thailand JCI hospital, full stop. 580 beds, JCI-accredited since 2002 (one of the first in Thailand), 47 specialty centers, 17 named endocrinology and metabolism MDs on the public roster. 1.1 million patients per year from 190 countries.

What we like: the depth is real. The Endocrinology, Diabetes & Clinical Nutrition Center is a named department, not a marketing page. Bumrungrad's Digestive Disease Centre published an ESG (endoscopic sleeve gastroplasty) + GLP-1 combination protocol — concrete evidence the GLP-1 menu is part of a real obesity-management programme, not a side bet. They also publish a Weight Management & DM Screening package, which is more pricing transparency than any of the other three give you.

What we don't: the GLP-1 per-month price ladder is consult-priced. The Mounjaro tracker that lists Bumrungrad explicitly is third-party — Bumrungrad's own diabetes-center page treats the GLP-1 stack as educational content, not a buyable menu. Premium global-medical-tourism markup is real; cohort-1 routing should match this provider to insured patients or to Thailand residents wanting maximum medical depth, not to nomads buying a pen.

Audit gap: pricing transparency caps out at 65/100 because of consult-priced GLP-1.

Samitivej Sukhumvit Hospital — 74 / 100, routable

The most concrete public-GLP-1-signal of the premium tier. JCI-accredited since 2007, Newsweek's #2 Thailand 2026, BDMS-affiliated (sister to Bangkok Hospital — important, see the concentration callout below). Sukhumvit Soi 49 puts it in the densest expat corridor for the Japanese and Korean expat communities, and the international-patient services desk reflects that.

What we like: Samitivej is the only hospital of the four that has both a published price ladder for an obesity programme — Life Fit, at ฿13,500 / ฿17,500 — and educational content on liraglutide weight-loss pens. That combination is the strongest public signal that adult weight management is a current, supported indication rather than a back-catalog mention. The Well-being Health Center + Genomic Lifestyle Wellness Center give the dose-accuracy and follow-through framing a real foothold.

What we don't: Life Fit is lifestyle and genomic-led, not GLP-1-menu-driven. The actual GLP-1 path runs through endocrinology consult, which is a step not visible on the package page. The pediatric-endocrinology center is more prominent on the site than the adult one — surprising, but doesn't change the underlying credentials.

Audit gap: the GLP-1 price isn't public; you'll find the consult fee but not the per-month for the pen until after the workup.

BNH Hospital — 71 / 100, routable

The 127-year Silom anchor. JCI + HA Thailand. Sala Daeng / Convent Road location is the long-standing default for the Sathorn / Silom corporate-expat corridor. Multilingual desk in EN / TH / CN / JP / MY / ID and international-insurance direct billing — for the Cigna / BUPA / Allianz Care patient population, BNH is the path-of-least-friction in Bangkok.

What we like: BNH's "Cardiometabolic Centre" and the BOOCS@BNH programme (a long-running behavioural-medicine-led metabolic intervention) point at metabolic depth that pre-dates the GLP-1 wave. That continuity matters — it's a centre with a metabolic muscle, not a clinic that pivoted into GLP-1 last quarter.

What we don't: BNH's public footprint on weight-management is the thinnest of the four. There's no published GLP-1 menu, no public price ladder for weight management. Routing here is endocrinology-consult-led, end of story. For an expat who wants the path-of-least-friction with their insurance and is comfortable booking a cardiometabolic consult and getting whatever the prescriber recommends, BNH is the best fit. For a buyer who wants menu-driven shopping, Samitivej or Bumrungrad will feel less opaque.

Audit gap: pricing transparency at 55/100 — the lowest of the four — because there is no published weight-management ladder.

BDMS Wellness Clinic — 68 / 100, conditional

The deliberate outlier in this comparison. BDMS Wellness Clinic at Wireless Road is the longevity / preventive-medicine flagship of the Bangkok Dusit Medical Services group — same parent corporate as Bangkok Hospital and Samitivej. Group buying power means the supply chain credibility, cold-chain, and procurement floor are hospital-grade.

The audit gap that pushes BDMS Wellness to conditional is real: the public site does not list GLP-1, semaglutide, tirzepatide, Ozempic, or Mounjaro anywhere we could find. The Longevity Card, the Centenarian 100 Blueprint, the telomere and epigenetic profile pages — all present. The molecule menu — absent in plain text. Pricing is stack-based: ฿4,200 to ฿179,000 across longevity programmes.

When does it route? When the buyer wants the longevity-frame around the GLP-1, not the GLP-1 directly. Telomere panels, epigenetic clock, biomarker tracking, peptide stack, dietitian, behavioural coach, and the GLP-1 fitting inside that — that's BDMS Wellness's pitch. For a straight Mounjaro pen pickup, this is the wrong door; send buyers to Bangkok Hospital flagship (BDMS group) or Bumrungrad. For a longevity-framed buyer who wants the GLP-1 inside a stack, BDMS Wellness is one of two places in Bangkok that do this credibly (the other being Chi Longevity / The Longevity GP in Singapore, both higher-cost, and the Ekkamai-tier Thai longevity clinics at lower cost).

Audit gap: dose-accuracy at 75/100 because the medical lead is longevity, not endocrinology.

The audit theme worth surfacing: BDMS group concentration

Three of the four — Samitivej, BDMS Wellness Clinic, and (off this list, but in the same orbit) Bangkok Hospital flagship — share a parent corporate in Bangkok Dusit Medical Services. That's good news on supply chain credibility (shared procurement, shared cold-chain protocols, shared BDMS-group buying power), and it's why all three score 80+ on cold-chain and compound identity.

It is also a real concentration risk for any expat who wants supply diversification. If a Bộ Y Tế-style or Thai-FDA enforcement event hits the BDMS group (a regulatory action against any of the BDMS-owned hospitals, an ownership transition, a wider TFDA shift on weight-loss prescribing), three of the four premium-tier providers move in correlated fashion. Bumrungrad (independent listed, BH on the SET) and BNH (Bangkok Hospital Network — a different corporate group, not BDMS, despite the name confusion) are the structural diversification.

For most buyer flows, the concentration risk doesn't matter. For long-tenure Thailand-resident expats running a multi-year GLP-1 protocol, it's worth knowing which corporate parent stands behind the provider you pick.

Decision tree

  • You want maximum medical depth and have the budget: Bumrungrad. Fullest public roster, most-cited globally, cleanest path to a peer-reviewed protocol around the GLP-1.
  • You want the most-explicit public GLP-1 awareness signal: Samitivej Sukhumvit. Life Fit + the published liraglutide content + the Newsweek ranking is the strongest "they prescribe and follow up on this" combination.
  • You want the path-of-least-friction with international insurance: BNH. The Sathorn / Silom corridor, EN / CN / JP / MY / ID / TH desks, insurance direct-billing. Less menu-shopping, more "your prescriber will tell you."
  • You want the longevity frame around the GLP-1, not the molecule directly: BDMS Wellness Clinic. Conditional rather than routable because the public site doesn't list GLP-1; route only when the buyer is choosing the stack, not the pen.
  • You want a clinic-tier price for an existing prescription: none of these — go down to the Ekkamai layer (Healthi Life and equivalents at panya.health/vendor).

Sources we audited against

Where Panya routes you

Take the 2-minute quiz. The match email gives you the specific premium hospital we route you to, the price band for the protocol you'll actually run, and the trade-offs we'd flag. We don't sell. We route.

If you want to read each scorecard directly, the per-hospital pages are at:

Tags:thailandbangkokglp-1buyers-guidetirzepatidesemaglutidemounjarovendor-comparisonexpat-asia

We earn a small commission when you buy through recommended vendors. That is how this stays free. Vendors rank by quality signals, not paid placement.